The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer

• Published in: Molecular imaging and biology Vol. 21; no. 1; pp. 1 - 10
• Main Authors: Paydary, Koosha, Seraj, Siavash Mehdizadeh, Zadeh, Mahdi Zirakchian, Emamzadehfard, Sahra, Shamchi, Sara Pourhassan, Gholami, Saeid, Werner, Thomas J., Alavi, Abass
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.02.2019; Springer Nature B.V
• Subjects: Biopsy; Bone imaging; Breast cancer; Breast Neoplasms - diagnosis; Breast Neoplasms - pathology; Breast Neoplasms - therapy; Cancer; Chemotherapy; Computed tomography; Diagnosis; Diagnostic systems; Female; Fluorodeoxyglucose F18; Glucose; Humans; Imaging; Lymphatic Metastasis; Medical diagnosis; Medicine; Medicine & Public Health; Metastases; Metastasis; Neoplasm Recurrence, Local - diagnosis; Neoplasm Recurrence, Local - pathology; Neoplasm Staging - methods; Neoplasm Staging - trends; Patients; Positron emission; Positron emission tomography; Positron Emission Tomography Computed Tomography - methods; Positron Emission Tomography Computed Tomography - trends; Prognosis; Radiology; Review Article; Scintigraphy; Sensitivity and Specificity; Tomography; Tumor markers; Breast neoplasms; [; Positron emission tomography/computed tomography; F]FDG; [18F]FDG

The applications of 2-deoxy-2-[ 18 F]fluoro- d -glucose positron emission tomography/X-ray computed tomography (PET/CT) in the management of patients with breast cancer have been extensively studied. According to these studies, PET/CT is not routinely performed for the diagnosis of primary breast ca...